Please login to the form below
Opioid
This page shows the latest Opioid news and features for those working in and with pharma, biotech and healthcare.
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
The Sacklers will be banned from the opioid industry in the US and internationally, while – as with the original settlement – the company will be dissolved or sold. ... chronic pain, unexpectedly became part of an opioid crisis that has brought grief
Latest news
-
US President Biden nominates Robert Califf as FDA commissioner
who said that she looked forward to working with him “to see our nation through this pandemic and to tackle other critical challenges like the ongoing opioid crisis, rising youth tobacco ... Manchin also said that “correcting the culture” at the
-
J&J, distributors reach $26bn settlement to address the opioid crisis in the US
The majority of the money will go towards opioid treatment and prevention initiatives in the US. ... According to the US Centers for Disease Control and Prevention (CDC), overdose deaths involving opioids have increased over six times since 1999.
-
PureTech adds potential IBD therapeutic to pipeline after buying out Alivio Therapeutics
In addition to LYT-500, PureTech will also add LYT-503/IMB-150 to its pipeline, a potential non-opioid treatment for interstitial cystitis or bladder syndrome which is currently being
-
Purdue to pay over $8bn to settle opioid-related criminal claims
The new company will provide opioid overdose reversal medication, as well as addiction treatment medications at no or low cost. ... It will also be permanently bound to injunctive relief, which includes marketing restrictions on the sale and promotion of
-
Mallinckrodt files for bankruptcy protection in the US
The bankruptcy filing will reduce Mallinckrodt’s debt by approximately $1.3bn and resolve the opioid-related claims against the company. ... Another opioid drugmaker – Purdue Pharma – filed for bankruptcy last year following increasing blame for
More from news
Approximately 37 fully matching, plus 151 partially matching documents found.
Latest Intelligence
-
Impact That Matters
Using portraits and quotes from people who use drugs, the campaign urges the community to carry naloxone – a life-saving opioid overdose reversal drug.
-
20 for 2020 – Five pharma leaders to watch in 2020
Hahn is taking over as the FDA is being thrust into the spotlight on a number of issues, including how to deal with medicine prices, the opioid epidemic, hastening access to
-
20 for 2020 – Five pharma companies to watch
year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... epidemic in opioid abuse and overdose-related deaths in the
-
Will biosimilars ever catch on in the US?
First-to-market generics included medicines for opioid overdose, pulmonary arterial hypertension, breast cancer, seizures, depression and various infections.
-
The transatlantic opioid crisis
There’s some evidence to suggest similar transgressions in the UK with opioids. ... In another case, a single GP had ten patients addicted to synthetic opioids.
More from intelligence
Approximately 2 fully matching, plus 26 partially matching documents found.
Latest appointments
-
New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals
DeVarney joined Titan over ten years ago, and has lead the development of its opioid addiction treatment Probuphine.
-
Egalet appoints Stan Musial as CFO
s pipeline of abuse-deterrent opioids are nearing phase III.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
But, over recent years, opioid overdose deaths have been steadily rising in the UK. ... 2, 644 people lost their lives to opioid-related overdoses in the UK in 2018.
-
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018. ... The two-day event succeeded in delivering what IOTOD is well known for: expert
-
IOTOD: Improving Opioid Dependence Outcomes
IOTOD’s future. The IOTOD educational initiative perpetually aims to provide the most up-to-date information in the field of opioid addiction. ... in opioid addiction and gain valuable insight on some of the most controversial topics in the field.
-
"Legal highs" ruling leaves illegal labs laughing
So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.
-
Research Partnership has published a new Living with Chronic Pain market report for 2016
At least 60% of the patients surveyed are currently prescribed long acting opioids (LAOs).
More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Almirall and Evotec team up in multi-target dermatology alliance
- NHS England appoints Chris Hopson as its new chief strategy officer
- Almirall launches Actinic Keratosis Global Day during Skin Cancer Awareness Month
- Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
- AbbVie submits Parkinson’s disease therapy to FDA
- When is an agency not an agency?
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- Kim Lemon appointed head of Liberation Unlimited
- Perrigo expands consumer health with €3.6bn Omega purchase
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
PMHub
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....
Latest intelligence
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
- Why big pharma needs to be braver
- The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
